Rupam Manna/LinkedIn
May 25, 2026, 14:57
Rupam Manna: Approach and Management of Deep Vein Thrombosis in Cancer
Rupam Manna, Postdoctoral Student – DrNB Medical Oncology at National Board of Examinations, shared a post on LinkedIn:
“Deep Vein Thrombosis (DVT) in Oncology is more than just a clot — it reflects the profound hypercoagulable state created by cancer itself.
From Virchow’s triad to modern anticoagulation strategies, understanding cancer-associated thrombosis is essential for every oncologist and physician.
- Always suspect DVT in any cancer patient with new unilateral swelling.
- Balance thrombosis risk against bleeding risk carefully.
- Early recognition saves lives.
Key concepts covered:
- Why cancer causes thrombosis
- High-risk cancers and drugs
- Diagnosis and Doppler approach
- LMWH vs DOACs
- Duration of anticoagulation
- Special situations: thrombocytopenia, brain mets, incidental PE and DVT”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session
-
Jul 13, 2026, 05:57Alberto Maino: ISTH 2026 Has Just Begun